Ingevity (NGVT) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $69.82, -1.02% vs the prior close of $70.54.
- Volume 179.58K shares, 0.7x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
NGVT dips 1.0% to $69.82. Closed at $69.82, -1.02% vs the prior close of $70.54. Day range $69.71–$71.78, opened at $70.60.
NGVT daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — NGVT dips 1.0% to $69.82
- Closed at $69.82, -1.02% vs the prior close of $70.54. Day range $69.71–$71.78, opened at $70.60.
- Volume was 179.58K shares, 0.7x its 50-day average of 250.09K.
- Price is -1.7% vs its 50-day average ($71.04) and -1.4% vs its 200-day average ($70.81).
- 52-week range $45.85–$79.29; today's close sits at 72% of that range, 11.9% below the 52-week high.
Oct 15, 2026 — NGVT rises 0.6% to $70.54, 3 up days in a row
- Closed at $70.54, +0.57% vs the prior close of $70.14. Day range $69.78–$71.23, opened at $70.53.
- Volume was 174.90K shares, 0.7x its 50-day average of 253.39K.
- Price is -0.9% vs its 50-day average ($71.19) and -0.3% vs its 200-day average ($70.76).
- 52-week range $45.85–$79.29; today's close sits at 74% of that range, 11.0% below the 52-week high.
- That makes 3 straight gains.
Oct 14, 2026 — NGVT ends flat (+0.1%) to $70.14
- Closed at $70.14, +0.09% vs the prior close of $70.08. Day range $69.05–$71.04, opened at $69.32.
- Volume was 291.50K shares, 1.2x its 50-day average of 253.14K.
- Price is -1.7% vs its 50-day average ($71.32) and -0.8% vs its 200-day average ($70.70).
- 52-week range $45.85–$79.29; today's close sits at 73% of that range, 11.5% below the 52-week high.
Oct 13, 2026 — NGVT rises 1.5% to $70.08
- Closed at $70.08, +1.46% vs the prior close of $69.07. Day range $68.74–$70.77, opened at $69.27.
- Volume was 318.20K shares, 1.3x its 50-day average of 252.72K.
- Price is -1.9% vs its 50-day average ($71.43) and -0.8% vs its 200-day average ($70.65).
- 52-week range $45.85–$79.29; today's close sits at 72% of that range, 11.6% below the 52-week high.
Oct 12, 2026 — NGVT dips 1.0% to $69.07
- Closed at $69.07, -0.99% vs the prior close of $69.76. Day range $68.90–$69.87, opened at $69.20.
- Volume was 280.50K shares, 1.1x its 50-day average of 253.05K.
- Price is -3.4% vs its 50-day average ($71.50) and -2.2% vs its 200-day average ($70.60).
- 52-week range $45.85–$79.29; today's close sits at 69% of that range, 12.9% below the 52-week high.
Oct 9, 2026 — NGVT dips 2.3% to $69.76
- Closed at $69.76, -2.31% vs the prior close of $71.41. Day range $69.52–$72.23, opened at $71.83.
- Volume was 224.00K shares, 0.9x its 50-day average of 257.77K.
- Price is -2.5% vs its 50-day average ($71.58) and -1.1% vs its 200-day average ($70.55).
- 52-week range $45.85–$79.29; today's close sits at 72% of that range, 12.0% below the 52-week high.
Oct 8, 2026 — NGVT rises 0.7% to $71.41
- Closed at $71.41, +0.69% vs the prior close of $70.92. Day range $70.44–$72.17, opened at $70.44.
- Volume was 245.30K shares, 0.9x its 50-day average of 260.60K.
- Price is -0.2% vs its 50-day average ($71.59) and +1.3% vs its 200-day average ($70.50).
- 52-week range $45.85–$79.29; today's close sits at 76% of that range, 9.9% below the 52-week high.
Oct 7, 2026 — NGVT dips 2.6% to $70.92
- Closed at $70.92, -2.58% vs the prior close of $72.80. Day range $70.72–$72.33, opened at $71.68.
- Volume was 330.90K shares, 1.3x its 50-day average of 257.39K.
- Price is -0.9% vs its 50-day average ($71.57) and +0.7% vs its 200-day average ($70.44).
- 52-week range $45.85–$79.29; today's close sits at 75% of that range, 10.6% below the 52-week high.
Oct 6, 2026 — NGVT dips 0.5% to $72.80
- Closed at $72.80, -0.46% vs the prior close of $73.14. Day range $72.20–$73.80, opened at $73.80.
- Volume was 237.70K shares, 0.9x its 50-day average of 256.53K.
- Price is +1.6% vs its 50-day average ($71.64) and +3.4% vs its 200-day average ($70.38).
- 52-week range $45.85–$79.29; today's close sits at 81% of that range, 8.2% below the 52-week high.
Oct 5, 2026 — NGVT rises 1.0% to $73.14, a 1-month high, 3 up days in a row
- Closed at $73.14, +1.01% vs the prior close of $72.41. Day range $71.26–$73.40, opened at $71.81.
- Volume was 297.80K shares, 1.2x its 50-day average of 254.40K.
- Price is +2.0% vs its 50-day average ($71.67) and +4.0% vs its 200-day average ($70.31).
- 52-week range $45.85–$79.29; today's close sits at 82% of that range, 7.8% below the 52-week high.
- That makes 3 straight gains.
Oct 2, 2026 — NGVT rises 1.9% to $72.41
- Closed at $72.41, +1.86% vs the prior close of $71.09. Day range $72.04–$73.65, opened at $72.28.
- Volume was 178.60K shares, 0.7x its 50-day average of 254.33K.
- Price is +1.0% vs its 50-day average ($71.68) and +3.1% vs its 200-day average ($70.23).
- 52-week range $45.85–$79.29; today's close sits at 79% of that range, 8.7% below the 52-week high.
NGVT latest news & SEC filings
Every SEC filing by or about NGVT in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Segal Francis David received an award of 335 shares at $71.09 (≈$23.82K) on Oct 1, 2026; now holds 8,947
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Willis J Kevin received an award of 405 shares at $71.09 (≈$28.79K) on Oct 1, 2026; now holds 11,883
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Li David H sold 92 shares at $74.71 (≈$6.87K) on Aug 18, 2026
- Li David H sold 92 shares at $74.71 (≈$6.87K) on Aug 18, 2026
- Li David H sold 92 shares at $74.71 (≈$6.87K) on Aug 18, 2026
- Li David H sold 92 shares at $74.71 (≈$6.87K) on Aug 18, 2026
- Li David H sold 5,000 shares at $75.83 (≈$379.15K) on Aug 17, 2026
- Li David H sold 5,000 shares at $75.83 (≈$379.15K) on Aug 17, 2026
- …plus 6 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Li David H sold 5,000 shares at $75.73 (≈$378.65K) on Aug 13, 2026
- Li David H sold 5,000 shares at $75.73 (≈$378.65K) on Aug 13, 2026
- Li David H sold 5,000 shares at $75.73 (≈$378.65K) on Aug 13, 2026
- Li David H sold 5,000 shares at $75.73 (≈$378.65K) on Aug 13, 2026
- Li David H sold 5,000 shares at $76.62 (≈$383.10K) on Aug 12, 2026
- Li David H sold 5,000 shares at $76.62 (≈$383.10K) on Aug 12, 2026
- …plus 2 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 12, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 11, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 30, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $314.10M (prior year $331.50M) (-5.2% vs Jun 30, 2025)
- Net income: $35.30M (prior year -$146.50M) (swung to profit vs Jun 30, 2025)
- Diluted EPS: $1.00 (prior year -$4.02) (swung to profit vs Jun 30, 2025)
Jul 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jun 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Things to know before you trade NGVT
- Last results release: Jul 29, 2026 (8-K Item 2.02). Previous ones: May 6, 2026, Feb 25, 2026, Nov 5, 2025. Based on that rhythm, the next report is likely around Oct 28, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.18% (largest 3.3%).
- Liquidity: about 255.48K shares (≈$17.84M) trade per day on average.
- 52-week position: $69.82 vs a range of $45.85–$79.29 (72% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: David H Li sold 92 shares on Aug 18, 2026.
- Latest filings: 10-Q Jul 30, 2026; 8-K Jul 29, 2026; 8-K Jun 24, 2026.
- Share count: 34.38M shares outstanding (Jul 24, 2026), -5.7% vs a year earlier — the company has been reducing its share count.
- Listing: NYSE · industry: Chemicals & Allied Products.
NGVT market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 70.60 | 71.78 | 69.71 | 69.82 | 179.58K |
| Oct 15, 2026 | 70.53 | 71.23 | 69.78 | 70.54 | 174.90K |
| Oct 14, 2026 | 69.32 | 71.04 | 69.05 | 70.14 | 291.50K |
| Oct 13, 2026 | 69.27 | 70.77 | 68.74 | 70.08 | 318.20K |
| Oct 12, 2026 | 69.20 | 69.87 | 68.90 | 69.07 | 280.50K |
| Oct 9, 2026 | 71.83 | 72.23 | 69.52 | 69.76 | 224.00K |
| Oct 8, 2026 | 70.44 | 72.17 | 70.44 | 71.41 | 245.30K |
| Oct 7, 2026 | 71.68 | 72.33 | 70.72 | 70.92 | 330.90K |
| Oct 6, 2026 | 73.80 | 73.80 | 72.20 | 72.80 | 237.70K |
| Oct 5, 2026 | 71.81 | 73.40 | 71.26 | 73.14 | 297.80K |
| Oct 2, 2026 | 72.28 | 73.65 | 72.04 | 72.41 | 178.60K |
| Oct 1, 2026 | 69.83 | 71.86 | 68.60 | 71.09 | 274.30K |
| Sep 30, 2026 | 71.42 | 71.42 | 69.81 | 70.75 | 406.20K |
| Sep 29, 2026 | 73.18 | 73.18 | 70.82 | 71.06 | 260.20K |
| Sep 28, 2026 | 72.12 | 73.29 | 71.58 | 72.74 | 230.60K |
| Sep 25, 2026 | 72.47 | 73.49 | 71.83 | 73.00 | 242.30K |
| Sep 24, 2026 | 71.16 | 72.03 | 70.67 | 71.79 | 194.80K |
| Sep 23, 2026 | 70.72 | 72.11 | 69.75 | 71.75 | 224.60K |
| Sep 22, 2026 | 70.13 | 71.68 | 69.36 | 71.27 | 291.20K |
| Sep 21, 2026 | 68.79 | 69.56 | 67.72 | 68.96 | 226.40K |
About Ingevity
Ingevity (NGVT) is listed on the NYSE and classified by the SEC under “Chemicals & Allied Products”. Its business address is in NORTH CHARLESTON, SC. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1653477.
NGVT board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Luis M Fernandez-Moreno | Director | May 1, 2026 |
| Diane H. Gulyas | Director | May 1, 2026 |
| Bruce D. Hoechner | Director | May 1, 2026 |
| David H Li | President & CEO | Aug 18, 2026 |
| Frederick J Lynch | Director | May 1, 2026 |
| Karen G Narwold | Director | May 1, 2026 |
| Francis David Segal | Director | Jul 2, 2026 |
| J Kevin Willis | Director | Jul 2, 2026 |
| Benjamin G. Wright | Director | May 1, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Ruth Castillo | SVP and Pres, Perf Materials | Mar 3, 2026 |
| Clarence Reid Jr. Clontz | SVP, Operations | Mar 3, 2026 |
| Ryan Joseph Cotterman | VP, Chief Accounting Officer | Jun 24, 2026 |
| Terrance M Dyer | SVP, Chief HR Officer | Jun 1, 2026 |
| Ryan C. Fisher | SVP, Gen. Counsel & Secretary | Aug 4, 2026 |
| Mary Dean Hall | EVP, Chief Financial Officer | Mar 3, 2026 |
| David H Li | President & CEO | Aug 18, 2026 |
| Phillip John Platt | SVP, Chief Financial Officer | Aug 11, 2026 |
| Michael N. Shukov | SVP and Pres, APT | Mar 3, 2026 |
| Richard Allen Jr White | SVP and Pres, Perf Chemicals | Mar 3, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 18, 2026 | David H Li | Sale | 92 | $74.71 |
| Aug 18, 2026 | David H Li | Sale | 92 | $74.71 |
| Aug 18, 2026 | David H Li | Sale | 92 | $74.71 |
| Aug 18, 2026 | David H Li | Sale | 92 | $74.71 |
| Aug 17, 2026 | David H Li | Sale | 5,000 | $75.83 |
| Aug 17, 2026 | David H Li | Sale | 5,000 | $75.83 |
| Aug 17, 2026 | David H Li | Sale | 5,000 | $75.83 |
| Aug 17, 2026 | David H Li | Sale | 5,000 | $75.83 |
| Aug 14, 2026 | David H Li | Sale | 5,000 | $75.73 |
| Aug 14, 2026 | David H Li | Sale | 5,000 | $75.73 |
| Aug 14, 2026 | David H Li | Sale | 5,000 | $75.73 |
| Aug 14, 2026 | David H Li | Sale | 5,000 | $75.73 |
| Aug 13, 2026 | David H Li | Sale | 5,000 | $75.73 |
| Aug 13, 2026 | David H Li | Sale | 5,000 | $75.73 |
| Aug 13, 2026 | David H Li | Sale | 5,000 | $75.73 |
NGVT financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $1.17B | $-167.10M | -4.61 | $331.20M |
| Dec 31, 2024 | $1.20B | $-430.30M | -11.85 | $128.60M |
| Dec 31, 2023 | $1.22B | $-5.40M | -0.15 | $205.10M |
| Dec 31, 2022 | $1.67B | $211.60M | 5.50 | $313.40M |
| Dec 31, 2021 | $1.39B | $118.10M | 2.95 | $293.30M |
Latest balance sheet: total assets $1.54B, total liabilities $1.49B, cash $97.40M (as of Jun 30, 2026).
NGVT earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 29, 2026 | 8-K Item 2.02 (results) | $70.62 |
| May 6, 2026 | 8-K Item 2.02 (results) | $77.87 |
| Feb 25, 2026 | 8-K Item 2.02 (results) | $69.60 |
| Nov 5, 2025 | 8-K Item 2.02 (results) | $54.46 |
| Aug 4, 2025 | 8-K Item 2.02 (results) | $40.85 |
| May 5, 2025 | 8-K Item 2.02 (results) | $35.52 |
| Feb 18, 2025 | 8-K Item 2.02 (results) | $45.84 |
| Jan 16, 2025 | 8-K Item 2.02 (results) | $46.46 |
| Oct 29, 2024 | 8-K Item 2.02 (results) | $35.32 |
| Jul 31, 2024 | 8-K Item 2.02 (results) | — |
| May 1, 2024 | 8-K Item 2.02 (results) | — |
| Feb 21, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Chemicals & Allied Products
Solstice Advanced Materials (SOLS)Olin (OLN)Fmc (FMC)Balchem (BCPC)Perimeter Solutions (PRM)Chemours (CC)Huntsman (HUN)Innospec (IOSP)Ecovyst (ECVT)Standard Lithium (SLI)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on NGVT
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.